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• Antibacterial 12-bis-THA/TFD hybrid nanoplexes are investigated 
• Nanoplexes-bacteria interaction are studied using membrane models and live cells 
• 12-bis-THA targets and sequesters LPS, delivering anti-inflammatory activity 
• 12-bis-THA-LPS interaction facilitates the entry of antimicrobial TFD in bacteria  
• Versatile nanoplexes against Gram -ve bacteria are a promising therapeutic option 
ABSTRACT The development of new therapeutic strategies against multidrug resistant Gram-
negative bacteria is a major challenge for pharmaceutical research. In this respect, it is 
increasingly recognized that an efficient treatment for resistant bacterial infections should 
combine antimicrobial and anti-inflammatory effects. Here, we explore the multifunctional 
therapeutic potential of nanostructured self-assemblies from a cationic bolaamphiphile, which 
target bacterial lipopolysaccharides (LPSs) and associates with an anti-bacterial nucleic acid to 
form nanoplexes with therapeutic efficacy against Gram-negative bacteria. To understand the 
mechanistic details of these multifunctional antimicrobial-anti-inflammatory properties, we 
performed a fundamental study, comparing the interaction of these nanostructured therapeutics 
with synthetic biomimetic bacterial membranes and live bacterial cells. Combining a wide 
range of experimental techniques (Confocal Microscopy, Fluorescence Correlation 
Spectroscopy, Microfluidics, NMR, LPS binding assays), we demonstrate that the LPS 
targeting capacity of the bolaamphiphile self-assemblies, comparable to that exerted by 
Polymixin B, is a key feature of these nanoplexes and one that permits entry of therapeutic 
nucleic acids in Gram-negative bacteria. These findings enable a new approach to the design 
of efficient multifunctional therapeutics with combined antimicrobial and anti-inflammatory 
effects and have therefore the potential to broadly impact fundamental and applied research on 
self-assembled nano-sized antibacterials for antibiotic resistant infections.  
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The rising resistance of bacteria to antibiotics is recognized as a major healthcare issue that, 
together with the scarcity of new therapeutic approaches, mandates the development of new 
antimicrobials acting upon novel bacterial targets[1]. Recently, the World Health Organization 
(WHO) published a list of antibiotic-resistant "priority pathogens", a catalogue of 12 families 
of bacteria that pose the greatest threat to human health, for which immediate research effort 
is required[2]. The list highlights the threat of resistant Gram-negative bacteria including 
Acinetobacter, Pseudomonas and various Enterobacteriaceae that are resistant to multiple 
antibiotics including last-resort agents such as carbapenems and third generation 
cephalosporins. 
The inherent antimicrobial resistance of Gram-negative bacteria is related to their unique 
structure: differently from Gram-positive ones, cell walls of Gram-negative bacteria are 
characterized by the presence of an asymmetric outer membrane containing >70% w/w of 
lipopolysaccharides (LPSs), the general structure of which is sketched in Figure 1. LPS consists 
of an immunogenic lipid portion embedded in the outer leaflet of the lipid bilayer (Lipid A), 
which is bound to an oligosaccharide moiety (R-core) and to an outer polysaccharide portion 
protruding from the membrane (O-antigen).[3,4] This thick and highly anionic layer, strongly 
anchored to the underlying membrane, acts as an efficient xenobiotic permeability barrier[5]. 
Besides its effects on bacterial resistance, LPS (also called endotoxin), when present in the 
bloodstream, can trigger uncontrolled inflammatory responses of the host, eventually leading 
to sepsis and death from septic shock.  
A rational approach to the development of effective therapeutics for systemic Gram-negative 
bacterial infections might include targeting of LPS for the dual purpose of enhancing cellular 
delivery of antimicrobial agents as well as blocking the immune response in advance of the 
onset of inflammation and sepsis. It has been recently demonstrated that the coagulation-related 
peptide, thrombin, binds and sequesters LPS, leading to accelerated aggregation and 
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phagocytic clearance of E. coli bacteria by macrophages in vitro.[6] More generally, LPS 
targeting, binding and removal from the circulation is an innate anti-inflammatory strategy 
prevalent in species spanning invertebrates to higher mammals. For example, host defense 
peptides or antimicrobial peptides (AMPs) are an intrinsic component of the innate immune 
system and are characterized by a broad-spectrum antimicrobial and anti-inflammatory 
activity.[7] As such, these peptides have received much attention as potential alternatives to 
traditional antibiotics. [8,9]  
In previous studies we presented a nanostructured antimicrobial, made of a cationic 
bolaamphiphile (12-bis-THA, the structure of which is displayed in Figure 1a) associating with 
a Transcription Factor Decoy (TFD), an aptamer designed to interfere specifically with the 
gene transcription mechanisms of the bacteria, to form nanosized complexes (hereafter termed 
loaded nanoplexes, LNP). Delivery of therapeutic TFDs to pathogenic bacteria is contingent 
upon co-formulation with the self-assembling 12-bis-THA amphiphile, which binds to and 
efficiently protects from nuclease degradation the DNA component[10]. 
LNPs have been shown to be a promising antimicrobial system against both Gram-positive 
and Gram-negative bacteria[10,11]. Their antibacterial efficacy is attributable to two distinct 
functions: first, a generic antimicrobial action of the cationic bolaamphiphile, interacting with 
and weakening cardiolipin-rich bacterial membranes; and secondly, a specific antimicrobial 
activity of the TFD towards selected genes involved in vital cellular functions of bacteria, such 
as metabolism and replication.[10] There is also an absence of known transcription factor-
mediated resistance pathways, which is a clear advantage over many conventional antibiotic 
targets. Besides TFD complexation and delivery, the amphiphilic and cationic nature of 12-bis-
THA, features shared with AMPs, makes these nanoplexes attractive as a possible LPS 
targeting species and for anti-inflammatory and antimicrobial purposes in the treatment of 
Gram-negative bacterial infections. 
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Figure 1. Systems under investigation. (Panel a) Antimicrobial nanoplexes: structure of the 12-bis-
THA cationic bolaamphiphile (whose assemblies are named empty nanoplexes, ENP); representative 
structure of a hairpin Transcription Factor Decoy (TFD); scheme sketching TFD and 12-bis-THA 
interaction to form loaded nanoplexes (LNPs). (Panel b) Membrane models: structure of the lipids 
employed in the membrane models: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 
Cardiolipin (CL); general structure of a Lipopolysaccharide (LPS), with the polysaccharide skeleton 
and the Lipid A moieties highlighted. Hep: Heptulose (ketoheptose); Kdo: 3-deoxy-α-D-
mannooctulosonic acid; P: phosphate. 
 
In this report, we perform a fundamental study on the interaction of LNPs with biomimetic and 
in vivo bacterial membranes, in order to explore and understand their potential as 
multifunctional experimental therapeutics for the treatment of Gram-negative bacterial 
infections. In this respect, our aim is twofold: first, to specifically investigate 12-bis-THA-TFD 
nanoplexes as possible antimicrobial and anti-inflammatory systems for Gram-negative 
bacterial infections; second, to contribute, more generally, to the progress of the fundamental 
knowledge on the interaction of antimicrobials with Gram-negative bacteria, which will help 
in the design of more efficient multifunctional therapeutics. To this aim, we study the 
interaction of LNP with synthetic mimics of Gram-negative bacteria, from two complementary 
standpoints: (i) bacterial membrane destabilization to achieve an efficient delivery of the 
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specific antimicrobial TFD into the bacterial cytoplasm (ii) LPS binding and sequestration for 
anti-inflammatory properties.  
An ensemble of experimental techniques, spanning the colloidal length scale down to 
molecular scale interactions, were combined to demonstrate that LNPs are a versatile system 
that destabilizes the bacterial outer membrane, promoting cell entry of the antimicrobial TFD, 
as well as exerting anti-inflammatory action through LPS sequestration. Therefore, LNPs 
represent multifunctional, tunable, colloidal systems with potential therapeutic efficacy against 
Gram-negative bacterial pathogens. As such, they have the potential to offer tailored anti-
infective treatment in healthcare settings that are increasingly challenged with antibiotic-
resistant pathogens. 
 
RESULTS AND DISCUSSION 
Interaction of nanoplexes with biomimetic Gram-negative bacterial membranes: 
Confocal Microscopy and Microfluidics  
In order to examine the interaction of LNPs with bacterial cell models, we prepared Giant 
Unilamellar Vesicles (GUVs) of different and controlled compositions, mimicking either 
Gram-negative or Gram-positive bacteria and challenged them with LNP. GUVs are primitive 
mimics not able to fully reproduce the complexity of natural membranes, however, their 
synthetic nature, allowing a fine control over their composition, geometry and environment, 
makes them a valuable model to investigate cell-membrane-related phenomena in simplified 
conditions, both related to eukaryotic[12,13] and to bacterial cells [14,15] ; here we employ 
GUVs containing the basic components of bacterial membranes, to assess the roles of 




Figure 2. Biomimetic bacterial model membranes. (a-e) Confocal microscopy images of GUVs 
made of: (a) POPC with 10% w/w CL and (b-e) POPC with 10% w/w CL, plus 17% w/w LPS: (a, b) 
representative images of GUVs containing the fluorescent tag Liss Rhod PE (red); (c-e) representative 
images of GUVs of POPC with 10% w/w CL, plus 17% w/w LPS containing the fluorescent lipid tags 
Bodipy (green) and Alexa-568-conjugated LPS (red) (the separated red (c) and green (d) channels and 
channel overlays (e) are displayed); (f) spatially resolved emission spectra at λexc 488 nm (green curve, 
excitation/emission of Bodipy) and λexc 561 nm  (red curve, excitation/emission of Alexa-568-
conjugated LPS) acquired on the same GUV membrane, highlighting the colocalization of the 
fluorescent tags. Scale bars 30 μm. 
As bacterial membrane mimics, we prepared GUVs composed of POPC and cardiolipin (CL), 
including or excluding 17% w/w LPS from E. coli. While CL is a membrane-specific lipid 
present both in Gram-positive and Gram-negative bacteria, LPS is unique to Gram-negative 
membranes and is of paramount relevance in determining the inefficacy of many antibacterial 
treatments. Figure 2 shows some representative Confocal Microscopy (CLSM) images of the 
Gram-positive POPC-CL model (Figure 2a) and the Gram-negative POPC-CL-LPS model 
(Figure 2b) GUVs, containing 0.1% mol:mol Liss Rhod PE, a fluorescent lipid, embedded in 
the lipid bilayer (red). The GUVs’ sections are visible as perfectly rounded circles, with Liss 
Rhod PE staining the lipid membrane shell. While the shape and size of the GUVs is similar in 
the absence and in the presence of LPS, a significant efficiency decrease of GUV’s yield 
prepared with the usual electroformation procedure was observed in the latter case, probably 
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due to the higher complexity of the lipid mixture and the increase of negatively charged species 
to be incorporated in the lipid assembly. In order to check the efficient incorporation of LPS in 
GUV membranes, we employed a fluorescently labeled LPS. Figure 2c-e display representative 
CLSM images of GUVs containing both the lipid fluorescent probe Bodipy (green) and Alexa 
568-labeled LPS (red) shown both as separate (2c, d) and overlaid (2e) channels. The 
colocalization of the fluorescence emission of the two probes confirms the successful inclusion 
of LPS in the GUVs, corroborated by the spatially resolved emission spectra (Figure 2f) 
acquired on the same GUV lipid membrane regions. 
 
Figure 3. Interaction of LNPs with biomimetic membrane models: CLSM images of GUVs 
fluorescently labeled with Liss Rhod PE (red) of: (a-c) POPC with 10% w/w CL and (d-g) with the 
same composition, plus 17% w/w LPS; 120 μL GUVs prepared as described in the experimental section, 
upon incubation with 20 μL (a-d) and 100 μL (e-g) of LNPs standard solution containing a fluorescent 
TFD (green); both separate channels and overlayed channels are displayed, with fluorescence 
colocalization areas seen in yellow. Scale bars 30 μm. 
Figure 3 displays some representative CLSM images of 120 μL GUVs (0.03 μg/μL lipid 
content, with or without LPS,), challenged with 100 μL of an aqueous dispersion of LNPs (0.18 
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mM 12-bis-THA and 10 μg/μL TFD), containing an AlexaFluor 488-labeled TFD (green). In 
this medium, LNPs have a size of 200 nm, and a zeta-potential in the order of +30 mV, similar 
to what previously shown[16]. When GUVs of POPC-CL were used, LNP docked at GUV 
membranes and fused with them after 2 h incubation (Figure 3a-c); in addition, part of the lipid 
probe originally staining the GUVs bilayer migrated into the aggregates (white arrows, Figure 
3a). This proves a close interaction between the LNPs and the GUVs, also in the absence of 
lipopolysaccharides in the GUVs, which is expected considering the negative charge of CL 
(see Figure 1b), and the positive z-potential of the nanoplexes.  
However, even low concentrations of LNPs, when added to GUVs containing LPS (Figure 3d), 
displayed extensive docking and fusion with the GUV membranes. Especially noticeable were 
extended regions of colocalization of the red lipid label with the green TFD and a clustering of 
the GUVs with LNPs acting as intervesicular bridges (white arrows, Figure 3d). These 
interactions were more pronounced with higher concentration of the LNPs (Figure 3 e-g), with 
many GUVs completely disrupted and the remaining ones extensively deformed and collapsed. 
To conclude, the presence of the LPS determines much more striking interactions between 
LNPs and the model lipid membranes. This effect is quite unexpected, considering that LPS 
act as a protective layer in Gram-negative bacteria, hindering the docking and penetration of 
exogenous species on bacterial membrane and, ultimately, their entry inside the bacterium. 
In order to understand the dynamic aspects of this interaction and better elucidate the GUV 
membrane disruption, we shifted our focus from static to dynamic experiments, monitoring the 
LNP-GUV interaction kinetics with confocal microscopy imaging combined with a customized 
microfluidic configuration, designed to trap and challenge GUVs with a solution[17].  
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Figure 4. Interaction of LNPs with target membranes: Microfluidics. (a) Experimental set-up for 
the microfluidics experiment; (b-d) representative CLSM time lapse images of (b) POPC-CL and (c, d) 
POPC-CL-LPS GUVs labeled as described in the main text in a 160 s (b, c) and 400 s (d) timescale; the 
overlay of Liss Rhod PE and Alexa 488 fluorescence, with colocalization area highlighted (yellow), 
and bright field (greyscale) are displayed. Scale bars 10 μm. 
Briefly, a PDMS (polydimethylsiloxane) microfluidic chip consisting of two inlets was secured 
upon a coverglass. Through the first inlet we injected the GUV’s dispersion, while the second 
one was for the subsequent injection of LNP dispersions (Figure 4a). From the first inlet, the 
injected GUVs flow through a microfluidic channel of 50 μm thickness and 350 μm width 
containing a series of U-shaped traps at defined channel positions. After GUVs trapping, LNPs 
stained with an Alexa 488-labeled TFD (green) were injected and the interaction monitored in 
real time. First, it should be highlighted that an optimal trapping of the GUVs inside the U-
shaped obstacles was challenging due to adhesion effects of LNPs on the channel walls and on 
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GUVs. Nevertheless, striking and unambiguous differences were observed in the absence and 
in the presence of LPS (compare the time evolution in Figures 4b and c). In the absence of LPS 
(Figure 4b), the docking of the LNPs at the GUV membrane was clearly visible, although no 
modifications in the shape of the GUVs were visible over a total LNP exposure time of 160 
seconds, which is consistent with the results of static CLSM observations. Conversely, in the 
presence of LPS (Figure 4c, d), there was a high tendency of the GUVs to interact extensively 
with LNPs, eventually causing the shrinkage of GUVs (Figure 4c) and, for longer interaction 
times (Figure 4d), even the implosion of the GUVs, probably due to a lipid extraction effect of 
the LNPs aggregates (see Supplementary Movies). Interestingly, the shrinkage and implosion 
of GUVs was observed only when LPS was included in the membrane formulation: this 
suggests that LNPs bind to LPS and extract it from the membrane. Control experiments 
confirmed that GUVs prepared with and without LPS were both stable throughout the 
experimental timescale (data not shown). 
These observations indicate that, contrary to current knowledge[18], the presence of LPS 
favors, rather than inhibits, the interaction of nanoplexes with the target GUVs. This finding is 
particularly interesting for two reasons: first, the dramatic membrane perturbation and local 
disruption of GUVs suggests a dramatic increase in membrane permeability, which would 
favor the delivery of TFD into the GUV lumen and might, therefore, favor the antimicrobial 
effect of LNPs against Gram-negative bacteria; second, the microfluidic experiment points at 
a specific binding of 12-bis-THA nanoplexes to the LPS component of the lipid membrane 
and, possibly, its selective extraction, eventually leading to the complete shrinkage of the GUV. 
This latter effect suggests that 12-bis-THA-TFD nanoplexes could bind and sequester 
immunogenic LPS, with anti-inflammatory consequences. 
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Nanoplexes as antimicrobials against Gram-negative bacteria: LPS-dependent delivery 
of TFD  
The antimicrobial activity of LNPs is dependent upon the delivery of TFD into the bacterial 
cytoplasm, so that vital cellular processes are repressed by competitive inhibition of 
transcription factor activity[19]. To monitor this ability, we performed a Fluorescence 
Correlation Spectroscopy (FCS) investigation on the penetration of a fluorescent TFD both into 
Gram-positive and Gram-negative biomimetic GUV membranes. Figure 5a shows 
representative FCS profiles acquired for the Alexa 488-labeled TFD alone (blue filled circles) 
and after interaction with 12-bis-THA, to form LNPs (red empty circles). 
 
Figure 5. Interaction of LNPs with target membranes: FCS. (a) Representative FCS curves of Alexa 
488-labelled TFD (blue filled circles) and of LNPs containing Alexa 488-labelled TFD (red empty 
circles), curve fitting of the experimental curves (continuous lines); (b, c) representative CLSM images 
of (b) POPC-CL and (c) GUVs after two hours incubation with LNPs; (d) Representative FCS curves 
of LNPs containing Alexa 488-labelled TFD measured for POPC-CL GUVs (green filled circles) and 
for POPC-CL-LPS GUVs (purple empty circles), inside GUVs’ lumen (as highlighted with colored 
spots in (b,c)). The continuous lines display the curve fitting of the experimental curves. 
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The FCS curve of the TFD could be analyzed with a two-component, three-dimensional normal 
diffusion model (see SI equation S5)[20–23], where the fast component has a diffusion 
coefficient D1 of 370 ± 40  μm
2s-1,while the slow component is characterized by D2 = 60 ± 20 
μm2s-1. The slower component is consistent with the diffusion of the dye conjugated to the 
oligonucleotide, while the fast component is clearly due to a small percentage of the dye not 
conjugated to the oligonucleotide, possibly through unavoidable nuclease contamination 
during non-sterile experimental procedures. However, through FCS these two components can 
be easily, reliably and precisely distinguished. In the presence of the bolaamphiphile, the TFD 
diffusion is clearly slowed down, due to the 12-bis-THA complexation with DNA and 
formation of nanoplexes. The diffusion coefficient of the complexed TFD, within the limits of 
accuracy of this experimental technique for objects of comparable size with respect to the size 
of the detection volume (see SI equation 3)[21], can be evaluated as: D= 1.9 ± 1 μm2s-1, 
consistent with nanoplexes of around 200 nm hydrodynamic diameter (SI equation S4). 
The LNPs were next incubated with the model Gram-positive cytoplasmic membrane, POPC-
CL (Figure 5b) and the model Gram-negative membranes, POPC-CL-LPS (Figure 5c) GUVs. 
Figure 5b and 5c report some representative CLSM images, consistent with the previously 
discussed phenomena (see Figure 3-4). In brief, LNPs interact closely with the lipid membrane 
of GUVs, docking and eventually fusing into it. However, no TFD accumulation is observed 
inside the GUVs’ lumen, and the LNPs’ aggregates remain largely confined on the surface of 
the lipid membrane. FCS measurements were performed inside POPC-CL and POPC-CL-LPS 
GUVs in order to verify if TFD, in complexed or free form, is released inside the GUVs’. 
Figure 5d shows the FCS curves acquired inside POPC-CL GUVs’ (green filled markers) and 
inside POPC-CL-LPS GUVs’ (purple empty markers), respectively. For POPC-CL GUVs the 
measured FCS profile can be interpreted according to a 1-component 3D fitting model, due to 
the sole presence of the free dye (D = 370 μm2s-1). For POPC-CL-LPS GUVs a second longer 
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decay is present. Using a two-component model, in which the fast-diffusing component is fixed 
at D = 370 μm2s-1, an estimate of the LNP intra-luminal diffusion coefficient was determined 
as D = 2.9 ± 0.6 μm2s-1. These observations indicate that the presence of the LPS on the lipid 
membrane not only promotes the interaction of the LNPs with the GUVs’ membrane, but also 
permits internalization of the nanoplexes smaller than the original ones (average hydrodynamic 
diameter 150 nm), suggesting a partial decomplexation when the LPS-containing membrane is 
crossed. 
 
Figure 6. Interaction of LNPs with live bacteria: FCS. (a, b) Representative CLSM images of E. 
coli bacteria upon incubation with LNPs containing Alexa 488-labelled TFD, Alexa 488 fluorescence 
(green) and bright field (greyscale) overlay; (c) five representative FCS curves of LNPs containing 
Alexa 488-labelled TFD measured inside E. coli cytoplasm (empty and filled markers), curve fit of the 
experimental data (continuous lines). The inset of (c) shows a representative brightfield CLSM image 
of E. coli cytoplasm where FCS has been measured. 
 In order to corroborate the data gathered on bacterial membrane mimics, we performed FCS 
on a live model Gram-negative bacterium, E. coli, to monitor the penetration of the 
fluorescently-labeled TFD into the bacterial cytoplasm. Clearly, FCS measurements on 
bacteria are particularly challenging due to the detection volume, which, in the z direction, is 
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slightly larger than the bacterium size. This latter limitation does not allow a precise estimate 
of the diffusion coefficient inside the detection volume. E. coli bacteria were challenged with 
LNPs containing Alexa 488-labeled TFD. After 1h 30' incubation at r.t. the bacteria were 
extensively washed in order to exclude surface-bound LNPs from the analysis. Figures 6a, b 
show the CLSM images of E. coli after incubation with LNPs: the green fluorescence of the 
Alexa 488-labeled TFD inside the bacterial cytoplasm suggests the successful uptake of TFD. 
Figure 6c displays five representative FCS curves acquired inside the bacterial cytoplasm of 
different E. coli cells. The clearly visible correlation decay is due to the diffusion of the TFD 
inside the bacterial cytoplasm. However, the FCS profiles were generally noisy, due to the 
complex and heterogeneous intracellular environment, united with a low fluorophore 
concentration. From these data, the reliable determination of a diffusion coefficient (and 
possibly a hydrodynamic size) is not possible. However, by fitting the experimental curves as 
due to a single component 3D diffusion, a diffusion coefficient of about 5 ± 2 μm2s-1 was 
inferred. This value is one order of magnitude higher than the diffusion coefficient of a lipidated 
Bodipy probe (molecular mass ~ 500 Da) sequestered in the cytoplasmic membrane of E. coli 
[24] and determined through FRAP (D= 0.6 ± 0.2 μm2s−1). This supports the claim that the 
fluorescent species diffuses in the cytoplasm, rather than the cell membrane, which has a 
considerably higher effective viscosity. In addition, if we compare this result with the diffusion 
coefficient obtained inside the LPS-containing GUVs (D = 2.9 ± 0.6 μm2s-1) and take into 
account that the bacterial cytoplasm is characterized by a higher viscosity with respect to 
water[24–26], we can conclude that inside the bacteria the TFD is, at least partially, 
decomplexed.  
Overall, these experiments prove the significant role of LPS in promoting membrane 




Nanoplexes as anti-inflammatory agents: LPS binding and sequestration.  
The observations highlighted above prompted us to investigate the mechanism of LPS 
sequestration by 12-bis-THA and its biological consequences. Using saturation transfer 
difference (STD) NMR spectroscopy[27] we sought to examine, at the molecular level, the 
extent and specificity of 12-bis-THA binding to liposomes of DOPC (1,2-dioleoyl-sn-glycero-
3-phosphocholine) in the absence and in the presence of LPS, taken as model membranes. STD 
NMR is appropriate for studying small-molecule binders of weak-medium affinity to large 
target molecules[28]. Through saturation of the target “receptor” molecule (which in this study 
is LPS bound to a liposome surface) and by studying the transfer to a bound ligand (here 
represented by 12-bis-THA), a map of ligand-receptor binding sites can be constructed. No 
STD signals were observed for samples containing 12-bis-THA and pure DOPC liposomes 
(Figure 7a, blue spectrum) indicating the absence of interaction in this system. In sharp 
contrast, many STD peaks were observed with DOPC liposomes containing LPS (Figure 7a, 
red spectrum), indicating extensive interaction between LPS-decorated liposomes and 12-bis-
THA (reference spectrum for which is shown in green, Figure 7a). The STD NMR technique 
affords an exquisite insight into the ligand domains that bind to a target macromolecule through 
the comparison of the extents of STD for different resonances after irradiation at different 
“receptor” frequencies[29]. For example, irradiation of LPS at different frequencies such as -4 
ppm for the lipophilic core, or 4.9 ppm and 5.2 ppm for the glucosamine rings GlcN-B and 
GlcN-A of LPS (Figure 1b), permits the construction of an epitope binding map, detailing the 
proximity of 12-bis-THA protons to the LPS binding site (Figure 7b). Careful analysis 
identified the orientation of the protons labeled here as C, E, I, F and K toward GlcN-A and 
GlcN-B (highlighted in Fig 1b). This region presents a positive charge located on the Nitrogen 
atom, which presumably makes contact with the negative charge located on the GlcN-A 
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orienting the head protons H, G, A, B, D away from this contact point (details of the binding 
orientation are in the Supplementary Information). It is also interesting to note that the protons 
labeled as M and N located in the center of the symmetrical linker, are oriented toward the 
aliphatic chains of DOPC/LPS liposome (Figure 7b). Following these arguments, one may 
conclude that the binding region of the 12-bis-THA on the LPS is centered on the GlcN-A 
negative charge, establishing close proximity with the positively charged Nitrogen atom at the 
polar head of 12-bis-THA, while the central protons of the lipophilic linker interact closely 
with the aliphatic region of the DOPC/LPS liposome. These data indicate that the interaction 
between 12-bis-THA and LPS is specific and not solely attributable to charge compensation. 
 
Figure 7: Binding of 12-bis-THA to LPS and its biological effects. (a) Structural formula of Lipid A 
(b) STD-NMR spectra of 12-bis-THA (400 μM) alone (green), in the presence of DOPC liposomes 
(blue) or DOPC:LPS liposomes (red). (c) Structural formula of one half of the symmetrical 12-bis-THA 
molecule overlaid with colored circles indicating proton orientation in LPS-containing model 
membranes. Green are protons oriented toward GlcN-A; magenta are protons oriented toward GlcN-B; 
yellow are protons oriented toward the aliphatic chains of DOPC/LPS liposome. (d) Dose-dependent 
effects of 12-bis-THA (empty circles) and PxB (filled circles) on nitric oxide release by RAW 264.7 
macrophages, determined by Griess assay of media nitrite levels. Data are mean of 3 independent 
experiments. Error bars are omitted for clarity. 
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Functional neutralization of LPS by 12-bis-THA was confirmed by in vitro studies with mouse 
RAW 264.7 macrophage cells. We challenged macrophages with E. coli LPS in the presence 
or absence of escalating concentrations of 12-bis-THA or polymyxin B (PxB), which was 
deployed as a gold standard LPS binder[30] used in the clinic as both an antibiotic[31] and 
endotoxin removal tool[32]. LPS-only controls consistently increased the nitrite concentration 
of the culture medium to > 10 M. The co-application of 12-bis-THA with LPS caused a 
concentration-dependent decrease in nitrite concentration, indicating reduced nitric oxide by 
macrophage cells i.e. an anti-inflammatory effect mediated through LPS sequestration. 
Strikingly, 12-bis-THA assemblies and PxB were of comparable potency at inhibiting nitric 
oxide release from macrophages in response to LPS (Figure 7c) with IC50 values of 5.1 and 0.5 
M, respectively. The viability of macrophage cells was not compromised across the 10 nM - 
100 μM concentration range tested, as judged by MTT assay (Supplementary Figures). These 
results indicate that the extracellular binding of LPS by 12-bis-THA is sufficient to prevent the 
acute pro-inflammatory response mediated through the cell surface toll-like receptor 4 receptor 
complex and the downstream inducible nitric oxide synthase (iNOS). Confiscation of blood-
circulating LPS in septic patients is a key research priority in light of the increasing number of 
Gram negative bacterial sepsis deaths worldwide[33]. The neutralization of LPS is a highly 
desirable characteristic that has been pursued by a number of groups who have employed a 
range of different scaffolds spanning the small and macromolecular size ranges [34–38]. 
CONCLUSIONS 
In this study we investigated the interaction of the nanostructured, antimicrobial 12-bis-
THA-TFD nanoplexes (LNPs) with Gram-positive and Gram-negative bacterial biomimetic 
membranes. We found that the interaction between the LNPs and Gram-negative bacteria 
critically involves LPS binding to 12-bis-THA nanoplexes which favors the docking of LNPs 
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to the bacterial membrane. These LNP-LPS interactions lead to two phenomena, both of 
paramount importance to future application of LNPs as efficient and multifunctional 
therapeutics for Gram-negative infections: (i) they induce membrane destabilization and 
increase membrane permeability, allowing the efficient delivery of antimicrobial TFDs into the 
bacterial cytoplasm; (ii) they afford LPS binding and sequestration, with its associated anti-
inflammatory effects, comparable with the golden standard PxB. These results demonstrate 
that the combination of 12-bis-THA and the TFD into nanoplexes represents a promising 
strategy to tackle Gram-negative bacterial infections, with a synergistic, multifunctional 
approach. In addition, the mechanistic insights on the interaction between nanoplexes and 
Gram-negative bacterial membrane models can be exploited to predict the antimicrobial-anti-
inflammatory behavior of different formulations based on cationic amphiphiles and nucleic 
acids and, therefore, will provide useful basic information for the design of novel effective 
therapeutics against antimicrobial resistant Gram-negative bacterial infections. Key mutations 
in LPS biosynthesis, such as sugar phosphorylation, lipid A modification or O-antigen 
deletions have been identified in Gram negative bacteria such as Pseudomonas aeruginosa 
isolated from chronically infected cystic fibrosis patients[39]. Binding between 12-bis-THA 
and mutant LPS from antimicrobial resistant Gram-negative bacteria as well as antibacterial 
activity is the subject of ongoing research and will be reported elsewhere. The concomitant 
anti-inflammatory activity of LNPs contributes a second, highly attractive attribute to this new 
drug delivery platform, making it an important tool in the fight against antibiotic-resistant 





POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phospho- choline), DOPC (1,2-dioleoyl-sn-
glycero-3-phosphocholine), Cardiolipin (sodium salt from bovine heart) and 
Lipopolysaccharide from Escherichia coli were acquired from Sigma Aldrich (St. Louis MO). 
12-bis-THA (1,10-(dodecane-1,12-diyl)-bis-(9-amino-1,2,3,4-tetrahydroacridinium) chloride, 
MW = 635.6 g/mol) was synthesized by Shanghai Chempartners co. (Denmark) with >98% 
purity. The TFD and its Alexa-488-labelled version were kindly provided to us by Procarta 
Biosystems Ltd. (Norwich, UK). Both non-labelled and Alexa 488-labelled oligonucleotide 
were specifically design to finally obtain a hairpin secondary structure according to the oligo 
analyser tool (version 3.1) from IDT-DNA free software and confirmed with the DINAMelt 
Web Server (University at Albany, USA). The lyophilized powder was first suspended in filter 
sterilised Milli-Q water to a concentration of 1 mg/ml. Once in dilution, the samples were 
incubated 5 minutes at 95°C and then let to cool down at room temperature to allow the 
complementary sequences to anneal. Then, there were kept at -20°C until used. 
12-bis-THA-TFD nanoplexes (LNP) preparation 
The dispersion of 12-bis-THA with chloride counter ion (0.18 mM) in aqueous solution was 
obtained by first dissolving the compound in milliQ-water. The homogenous dispersion in 
water was then obtained by vigorous stirring with vortex, leading to the formation of empty 
nanoplexes (ENPs). Similarly, loaded nanoplexes (LNPs) were obtained by adding the 
bolaamphiphile dispersion (0.18 mM) to a solution containing the TFD in milliQ-water (10 
μg/mL) and stirring the mixture with vortex for 30 seconds. When required, Alexa Fluor 488-
labelled TFD was used.  
Membrane models preparation 
Giant Unilamellar Vesicles were prepared through electroformation, as described 
elsewhere[40]. Lipid composition was 90% w/w POPC and 10% w/w Cardiolipin (plus 17% 
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w/w LPS for LPS containing GUVs) and 0.1% (for confocal microscopy imaging) or 0.01% 
(for Fluorescence Correlation Spectroscopy experiments) with respect to the total lipid amount 
of the fluorescent dyes (β-Bodipy or Liss Rhod PE) was added. The dispersions of GUVs in 50 
mM Sucrose were employed within 24 hours after preparation for CLSM and FCS experiments. 
Further details are in the SI. 
For NMR experiments, 20 mg/mL dispersions of DOPC and DOPC:LPS (50% w/w) liposomes 
in D2O, were prepared according to a standard protocol of dry lipid film hydration, freeze-thaw 
and sonication[41], which is described in details in the SI. 
Confocal Laser Scanning Microscopy 
CLSM experiments were carried out with a laser scanning confocal microscope Leica TCS SP8 
(Leica Microsystems GmbH, Wetzlar, Germany) equipped with a 63x water immersion 
objective.[42] The 488 nm laser line was employed to detect β-Bodipy fluorescence and Alexa 
488-labeled TFD (λ excitation 488 nm, λ emission 498 nm - 530 nm); the 561 nm laser line 
was employed to detect Liss Rhod PE dye inside the GUVs' membrane or Alexa 568-labeled 
LPS (λexcitation 561 nm, λ emission 571 nm - 650 nm). Samples containing LNPs and GUVs 
were incubated for one hour before the acquisition of the images. Further details are in the SI. 
Microfluidics experiments  
Polydimethylsiloxane (PDMS) - glass microfluidic chips were fabrication is reported in the SI. 
50 µL of the solution obtained by electroformation was diluted to 1 mL with a 15 mM aqueous 
sucrose solution, filtered at 0.2 µm. The obtained solution was injected in one inlet of a Y-
shaped microfluidic channel (Figure 4), while a diluted (1:10) LNPs standard solution with 
Alexa-488-labelled TFD was injected in the other inlet. The flow rates of the injected GUVs 
and LNPs, ranging from 0.1 to 1 μL/min, were controlled thanks to two syringes connected to 
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a syringe pump (Nemesys, Cetoni GmbH) by standard tubing (1/16’’ OD, 0.81mm ID). In a 
microfluidic experiment first GUVs were injected at 1 μL/min and LNPs at 0.1 μL/min, to 
achieve efficient GUVs trapping without significant exposure to LNPs, then the flow rate was 
reversed to 0.1 μL/min for GUVs and 1 μL/min for LNPs to expose GUVs to LNPs. Chips 
were put under vacuum for at least 20 min before the experiments to reduce bubble trapping 
during channel filling. Characterization was achieved by imaging, by Confocal Laser Scanning 
Microscopy CLSM (Leica TCS SP8). 
Fluorescence Correlation Spectroscopy 
FCS measurements were carried out using a Leica TCS SP8 confocal microscope (Leica 
Microsystems GmbH, Wetzlar, Germany) equipped with a PicoQuant FCS modulus 
(PicoQuant, Berlin, Germany). Measurements were performed using a 63x water immersion 
objective. The fluorescently-labeled TFD and Rhodamine 110 for calibration of the confocal 
volume were excited using the 488 nm-laser line of an Ar laser and the fluorescence emission 
was acquired using a Hybrid SMD detector in the 498–530 nm range. 
For experiments on TFD release inside GUVs 120 µL GUVs dispersion in Sucrose was put in 
measurement wells (Lab-Tek Chambered 1.0 Borosilicate Coverglass System, Nalge Nunc 
International, Rochester, NY USA) and diluted with 80 μL Glucose 50 mM.  100 μL (for 
POPC-CL GUVs) or 20 μL (for POPC-CL-LPS GUVs) of LNPs standard solution prepared as 
previously described, with Alexa-labelled TFD, were added to the dispersion. Samples 
containing LNPs and GUVs were incubated for one hour before the acquisition of FCS curves 
inside GUVs lumen. 
For FCS experiments on E. coli a bacterial dispersion in H2O was incubated with the same 
volume of LNPs (prepared with Alexa 488-labeled TFD). To visualize the bacteria in confocal 
microscopy and to carry out FCS experiments, the bacteria were layered on the bottom of 
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appropriate wells, which were pre-treated with polylysine, to favor bacterial adhesion on the 
coverglass. The dispersion of bacteria or bacteria and LNPs was allowed to interact with the 
polylysine layer for 1h at r.t. in a humidity-controlled chamber, then the supernatant was 
removed and the bacterial layer inside the wells was extensively washed with H2O and then 
diluted with 300 µL H2O. FCS experiments in bacteria were carried out by focusing with 
CLSM the confocal volume in the center of cells' cytoplasm and then acquiring FCS curves. 
All details on FCS data analysis are reported in the SI. 
Saturation Transfer Difference NMR spectroscopy 
1H NMR Saturation transfer difference experiments were acquired on a Bruker AVANCE 500 
MHz at 298K. To a solution of 12-bis-THA 400 µM in D2O was added a suspension of 
LPS/DOPC liposomes or only DOPC liposomes in D2O at the final concentration of 2 µM of 
LPS considering a MW of 10 kDa for the LPS. Shortly after that, the sample was transferred 
in 5 mm NMR tubes for spectra acquisition. The saturation transfer difference (STD) 
experiment was acquired using the Bruker library pulse stddiffesgp with a SW of 16 ppm a TD 
of 32K a relaxation delay (D1) of 6 seconds and a variable time for the train of the selective 
saturating 90° Gaussian pulse, from 0.5 to 6 s. The spectra were acquired with 32 or 64 scans. 
The saturation pulse (ON) was positioned in three different regions of the spectra, at -4.0 ppm, 
4.9 ppm and 5.2 ppm. These resonances were chosen as representative of the lipophilic core of 
the LPS/DOPC liposome, GlcN-B and GlcN-A of LPS respectively. The OFF pulse was always 
positioned at 40 ppm and the spectra obtained were used as a reference. With the aim to obtain 
insight of the binding orientation of the 12-bis-THA to the LPS the epitope mapping protocol 
was used. The saturation received from the proton of the ligand is calculated considering the 
STD build-up curve in a time course experiment using a variable time for the saturation pulse 
from 0.5 to 6 seconds. The data were fitted to the equation STD=STDmax * (1-exp(-K*t) from 
where the STD0 was calculated as STDmax*K = STD0.[43]  
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Inhibition of nitric oxide production by macrophage cells 
The murine macrophage RAW 264.7 cell line (American Type Culture Collection, USA) was 
maintained at 37 °C in DMEM supplemented with 10% heat inactivated fetal bovine serum, in 
a 5% CO2 incubator. Cells were seeded onto 96 well plates (10
5 per well) and grown overnight. 
Culture medium was removed and replaced with 0.1 mL fresh medium supplemented with 500 
ng E. coli LPS alone or LPS combined with escalating concentrations of 12-bis-THA or PxB. 
After 24 h, media was removed, centrifuged briefly (200 x g, 5 min) to remove any cellular 
material and then subjected to a Griess Assay[44] to determine media nitrite concentration as 
an indicator of nitric oxide production by iNOS.  
SUPPORTING INFORMATION 
Supplementary Materials and Methods (PDF), Microfluidic movie of POPC-CL and POPC-
CL-LPS GUVs interacting with LNPs (.avi)   
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